Lid Wiper Epitheliopathy in Patients with Dry Eye Refractory to Conventional Medical Treatment
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Huh, Jungah | - |
dc.contributor.author | Woo, In Ho | - |
dc.contributor.author | Eom, Youngsub | - |
dc.contributor.author | Kang, Su-Yeon | - |
dc.contributor.author | Kim, Hyo Myung | - |
dc.contributor.author | Song, Jong-Suk | - |
dc.date.accessioned | 2021-09-02T08:03:55Z | - |
dc.date.available | 2021-09-02T08:03:55Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-08 | - |
dc.identifier.issn | 0378-6471 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/73889 | - |
dc.description.abstract | Purpose: We evaluated the effects of lid wiper epitheliopathy on the clinical manifestations of dry eye in patients refractory to conventional medical treatment. Methods: Forty-six patients (46 eyes) completed the subjective Ocular Surface Disease Index (OSDI), and we obtained objective measures including the tear break-up time (TBUT), the National Eye Institute (NEI) corneal staining score, tear osmolarity, and lid wiper epitheliopathy as revealed on photographs taken using a yellow filter after fluorescein instillation. The images were graded using the Korb B protocol. Results: The mean OSDI score was 48.06 +/- 21.19; 34 patients (73.9%) were had scores >= 33. Lid wiper epitheliopathy was evident in 41 (89.1%), and the epitheliopathy grade and OSDI score were correlated (r = 0.56, p < 0.01). The NEI score was also positively correlated with the OSDI score (r = 0.54, p < 0.01), but the mean value was low (1.59 +/- 2.13). The OSDI score did not correlate significantly with either the TBUT or tear osmolarity (r = -0.16, p = 0.279; r = 0.16, p = 0.298, respectively). Conclusions: Lid wiper epitheliopathy was present in about 90% of patients with dry eye who visited our tertiary hospital, and a significant correlation was evident between the epitheliopathy grade and the OSDI score. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.publisher | KOREAN OPHTHALMOLOGICAL SOC | - |
dc.subject | TEAR OSMOLARITY | - |
dc.subject | SYMPTOMS | - |
dc.subject | DISEASE | - |
dc.subject | SIGNS | - |
dc.title | Lid Wiper Epitheliopathy in Patients with Dry Eye Refractory to Conventional Medical Treatment | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Eom, Youngsub | - |
dc.contributor.affiliatedAuthor | Song, Jong-Suk | - |
dc.identifier.doi | 10.3341/jkos.2018.59.8.718 | - |
dc.identifier.wosid | 000471839300003 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, v.59, no.8, pp.718 - 723 | - |
dc.relation.isPartOf | JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY | - |
dc.citation.title | JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY | - |
dc.citation.volume | 59 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 718 | - |
dc.citation.endPage | 723 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002373542 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Ophthalmology | - |
dc.relation.journalWebOfScienceCategory | Ophthalmology | - |
dc.subject.keywordPlus | TEAR OSMOLARITY | - |
dc.subject.keywordPlus | SYMPTOMS | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | SIGNS | - |
dc.subject.keywordAuthor | Correlation | - |
dc.subject.keywordAuthor | Dry eye | - |
dc.subject.keywordAuthor | Lid wiper epitheliopathy | - |
dc.subject.keywordAuthor | Medical | - |
dc.subject.keywordAuthor | Refractory | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.